• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腹膜癌病临床分期的评分系统。批判性分析]

[Scoring systems for clinical staging of peritoneal carcinomatosis. A critical analysis].

作者信息

Jähne J, Kübler S

机构信息

Klinik für Allgemein- und Viszeralchirurgie, Schwerpunkt für endokrine und onkologische Chirurgie , Diakoniekrankenhaus Henriettenstiftung gGmbH, 30171, Hannover.

出版信息

Chirurg. 2007 Dec;78(12):1091-5, 1097-9. doi: 10.1007/s00104-007-1426-1.

DOI:10.1007/s00104-007-1426-1
PMID:17989944
Abstract

For peritoneal carcinomatosis, several different classification and scoring systems for clinical staging have been proposed and used by the different centers worldwide engaged in treating this clinical entity. Of highest clinical relevance are the classifications assessing tumor distribution and size and those describing the degree of surgical cytoreduction. Allocation of patients to different stages is based on clinical intraoperative evaluation and therefore is subjective and observer-dependent. The various classification systems are presented and discussed regarding applicability, exactness, and their value as either selection criterion or prognostic instrument.

摘要

对于腹膜癌病,全球不同治疗该临床实体的中心已提出并使用了几种不同的临床分期分类和评分系统。临床相关性最高的是评估肿瘤分布和大小的分类以及描述手术细胞减灭程度的分类。将患者分配到不同阶段是基于临床术中评估,因此具有主观性且依赖观察者。本文将介绍并讨论各种分类系统在适用性、准确性以及作为选择标准或预后工具的价值方面的情况。

相似文献

1
[Scoring systems for clinical staging of peritoneal carcinomatosis. A critical analysis].[腹膜癌病临床分期的评分系统。批判性分析]
Chirurg. 2007 Dec;78(12):1091-5, 1097-9. doi: 10.1007/s00104-007-1426-1.
2
Quantitative prognostic indicators of peritoneal dissemination of gastric cancer.胃癌腹膜播散的定量预后指标。
Eur J Surg Oncol. 2006 Aug;32(6):602-6. doi: 10.1016/j.ejso.2006.03.003. Epub 2006 Apr 17.
3
The intraoperative staging systems in the management of peritoneal surface malignancy.腹膜表面恶性肿瘤治疗中的术中分期系统
J Surg Oncol. 2008 Sep 15;98(4):228-31. doi: 10.1002/jso.21068.
4
Quantitative prognostic indices in peritoneal carcinomatosis.腹膜癌病的定量预后指标。
Eur J Surg Oncol. 2006 Aug;32(6):597-601. doi: 10.1016/j.ejso.2006.03.002. Epub 2006 Apr 17.
5
[Staging videolaparoscopy of peritoneal carcinomatosis].[腹膜癌病的分期视频腹腔镜检查]
Tumori. 2003 Jul-Aug;89(4 Suppl):70-7.
6
Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings.黏液性阑尾肿瘤:术前磁共振成像分期及分类与手术及组织病理学结果的比较
AJR Am J Roentgenol. 2008 Mar;190(3):656-65. doi: 10.2214/AJR.07.2018.
7
[Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].[胃肠道原发性腹膜癌患者的外科治疗]
Z Gastroenterol. 2006 Dec;44(12):1237-45. doi: 10.1055/s-2006-927156.
8
[Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].[结直肠癌腹膜癌转移:细胞减灭术与腹腔热灌注化疗]
Dtsch Med Wochenschr. 2011 Sep;136(36):1811-4. doi: 10.1055/s-0031-1286108. Epub 2011 Aug 31.
9
Natural history of peritoneal carcinomatosis from nongynecologic malignancies.非妇科恶性肿瘤所致腹膜癌病的自然病史。
Surg Oncol Clin N Am. 2003 Jul;12(3):729-39, xiii. doi: 10.1016/s1055-3207(03)00044-9.
10
Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features.结直肠癌腹膜转移瘤细胞减灭术及腹腔内化疗后的二次探查手术:预后特征分析
World J Surg. 1999 Jan;23(1):23-9. doi: 10.1007/s002689900560.

引用本文的文献

1
[Advanced gastric cancer. Are there still indications for palliative surgical interventions?].[进展期胃癌。姑息性手术干预是否仍有指征?]
Chirurg. 2012 May;83(5):472-9. doi: 10.1007/s00104-011-2143-3.

本文引用的文献

1
Computed tomographic characterization of malignant peritoneal mesothelioma.恶性腹膜间皮瘤的计算机断层扫描特征
Tumori. 2005 Sep-Oct;91(5):394-400. doi: 10.1177/030089160509100503.
2
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.细胞减灭术联合腹腔热灌注:采用封闭腹腔技术治疗209例腹膜表面恶性肿瘤的发病率和死亡率分析
Cancer. 2006 Mar 1;106(5):1144-53. doi: 10.1002/cncr.21708.
3
Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
术前计算机断层扫描与结直肠腹膜癌转移患者的细胞减灭术及术中腹腔内热化疗的患者选择
Eur J Surg Oncol. 2006 Feb;32(1):65-71. doi: 10.1016/j.ejso.2005.09.016. Epub 2005 Nov 14.
4
Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution.腹膜弥漫性恶性间皮瘤:对在单一机构接受局部治疗的35例患者的临床病理研究
Cancer. 2005 Nov 15;104(10):2181-8. doi: 10.1002/cncr.21239.
5
Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion.
Ann Surg Oncol. 2005 Nov;12(11):910-8. doi: 10.1245/ASO.2005.11.030. Epub 2005 Sep 21.
6
Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.细胞减灭术联合腹腔内热化疗治疗腹膜假黏液瘤:一项前瞻性研究。
Dis Colon Rectum. 2005 Jul;48(7):1372-9. doi: 10.1007/s10350-005-0045-5.
7
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer.胃肠道癌腹膜转移的预后指标
Int Semin Surg Oncol. 2005 Feb 8;2(1):3. doi: 10.1186/1477-7800-2-3.
8
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy.腹膜假黏液瘤治疗后的长期生存:手术治疗分析
Ann Surg. 2005 Feb;241(2):300-8. doi: 10.1097/01.sla.0000152015.76731.1f.
9
Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy.腹部计算机断层扫描在选择接受细胞减灭术和围手术期腹腔内化疗综合治疗的恶性腹膜间皮瘤患者中的应用
Cancer. 2005 Feb 15;103(4):839-49. doi: 10.1002/cncr.20836.
10
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance.腹膜癌灶完全切除术后术中腹腔内热灌注奥沙利铂联合伊立替康:药代动力学、组织分布及耐受性
Ann Oncol. 2004 Oct;15(10):1558-65. doi: 10.1093/annonc/mdh398.